#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Soft tissue necrosis Pleural mesothelioma Breast cancer Spinal cord injury Neuroblastoma Hypertriglyceridaemia Undifferentiated sarcoma Pulmonary alveolar haemorrhage Gastrointestinal stromal tumour Metachromatic leukodystrophy MELAS syndrome Congenital disorder of glycosylation Metastases to peritoneum Cerebral arteriovenous malformation haemorrhagic Vascular malformation More trials…

    Learn about Rare Diseases

    Anaplastic thyroid cancer Alport’s syndrome – Life with Disease Familial haemophagocytic lymphohistiocytosis – Treatment Pelizaeus-Merzbacher disease – Treatment Hereditary neuropathic amyloidosis – Diagnostics Rhabdoid tumour – Diagnostics Lymphatic malformation – Trials in Disease Waldenstrom’s macroglobulinaemia – Diagnostics Propionic acidaemia – Diagnostics Mastocytosis – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Mosaic Hbcoreag Clindamycin Hydrochloride Levonorgestrel Ruxotemitide Mifamurtide Adalimumab Evg321 Sitagliptin CICLOPIROX Ampicillin Cx-037231 2,4 DICHLOROBENZYL ALCOHOL Acetylcysteine Moxifloxacin Hydrochloride Kk8123 Nifedipine GLYCYL-TYROSINE Glipizide Napabucasin Belzutifan More therapies…

    Learn about Your Condition

    Orthostatic hypotension Dedifferentiated liposarcoma Mixed-type liposarcoma Bile duct adenocarcinoma Biliary adenoma Pertussis Alveolar bone defect Pharyngeal cancer stage II Breast angiosarcoma Multiple sclerosis relapse Antithrombin III deficiency Cerebral palsy Hyperlipidaemia Pancreatitis acute Breast cancer stage II More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Cardiomyopathy

  • Testing allogeneic adipose tissue-derived mesenchymal stromal cells in patients with recently diagnosed non-ischemic heart failure with reduced ejection fraction

    Not recruiting

    2 1
    Investigated Diseases:
    • Cardiomyopathy
    Denmark

  • Study on the Effectiveness of Autologous Bone Marrow Cells for Patients with Dilated Cardiomyopathy and Heart Failure

    Not recruiting

    2 1
    Investigated Diseases:
    • Cardiomyopathy
    • Dilated cardiomyopathy
    Investigated Drugs:
    • Autologous Bone Marrow-Derived Adult Mononuclear Cells, Not Expanded
    Spain

  • Study on Dapagliflozin to Prevent Heart Damage in Breast Cancer Patients Receiving Anthracycline Chemotherapy

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    • Dapagliflozin
    Poland

  • Study on the Safety and Effects of OMT-28 for Patients with Primary Mitochondrial Disease and Muscle or Heart Problems

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Cardiomyopathy
    Investigated Drugs:
    • 2-{[(8Z)-13-[(Methylcarbamoyl)Formamido]-Tridec-8-En-1-Yl]Oxy}Acetic Acid
    Germany Italy The Netherlands

  • Study on the Effects of Mycophenolate Mofetil and Prednisolone in Patients with Chronic Virus-Negative Inflammatory Cardiomyopathy

    Not recruiting

    4 1 1
    Investigated Diseases:
    • Cardiomyopathy
    Investigated Drugs:
    • Mycophenolate Mofetil
    • Prednisolone
    Germany
Previous Page
1 2

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!